Keita Uchino

Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)

Akitaka Makiyama, Yasutaka Sukawa, Tomomi Kashiwada et al. · Journal of Clinical Oncology · 2020 · 197 citations

Medicine, Oncology, Pharmacotherapy +16

Therapeutic Effects of MicroRNA-582-5p and -3p on the Inhibition of Bladder Cancer Progression

Keita Uchino, Fumitaka Takeshita, Ryou‐u Takahashi et al. · Molecular Therapy · 2013 · 117 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody

Hirofumi Ohmura, Fumiyasu Hanamura, Mamoru Ito et al. · British Journal of Cancer · 2020 · 87 citations · Full text

Life Sciences, Immunology, Oncology +17

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer

Akitaka Makiyama, Kohei Arimizu, Gen Hirano et al. · Gastric Cancer · 2017 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)

Yuji Miura, Yasutaka Sukawa, Shuichi Hironaka et al. · Gastric Cancer · 2017 · 45 citations · Full text

Medicine, Oncology, Pharmacology +15